RecruitingNot ApplicableNCT04434586

Contribution of Optical Coherence Tomography in the Endovascular Treatment of Femoral Occlusions


Sponsor

University Hospital, Lille

Enrollment

166 participants

Start Date

Jun 16, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

This is a common care study. A study for evaluating the quality of balloon inflation and stent application will be performed in 2D angiography alone in the control group and then by 2D and OCT angiography for the experimental group. The benefit could be an improvement in the results of revascularization of femoropopliteal lesions thanks to OCT which allows a 3D visualization of the arterial lumen.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called femoropopliteal revascularization for TASC C or TASC D lesion for people with claudication, ischemic leg, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEfemoropopliteal revascularization for TASC C or TASC D lesion

Femoropopliteal revascularization: ATL or ATL/stenting for TASC C/D lesions. Control group: only angiography 2D final control. Experimental group: angiography + OCT control


Locations(1)

Insitut Coeur-Poumon, CHU

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04434586


Related Trials